Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -20.08% |
| 2024 | 14.12% |
| 2023 | 11.31% |
| 2022 | 7.04% |
| 2021 | 80.12% |
| 2020 | 98.43% |
| 2019 | 92.37% |
| 2018 | 0.00% |